Highest-materiality recent filing
Adamas Trust announces $90M offering of 9.600% Senior Notes due 2031
$90M aggregate principal amount of 9.600% Senior Notes due 2031 sold to underwriters.
Adamas Trust raises quarterly common dividend 11.1% to $0.30/share
Quarterly dividend increased to $0.30 per share from $0.27 per share paid in Q2 2026.
Adamas Trust Q2 2026: EPS $0.48, EAD $0.30 (+36% YoY), book value $10.16 (+1.8% QoQ)
GAAP basic EPS $0.48; EAD per share $0.30, up 36.4% YoY and 3.4% QoQ.
Adamas Trust Q1 EPS $0.41, EAD $0.29 (up 45% YoY); book value up 4%
GAAP basic EPS $0.41; EAD per share $0.29, up 45% YoY and 26% QoQ.
Adamas Trust Q4 net income $41.6M ($0.46 EPS); FY net income $101.1M; EAD per share $0.23
FY 2025 net income $101.1M ($1.12 EPS); Q4 net income $41.6M ($0.46 EPS).
Adamas Trust completes $90M offering of 9.250% Senior Notes due 2031
Issued $90M aggregate principal of 9.250% Senior Notes due April 1, 2031.
NYMT rebrands to Adamas Trust, tickers change to ADAM; acquires $2.1B in residential assets
Name change to Adamas Trust, Inc. effective 9/3/25; common stock ticker changes from NYMT to ADAM on Nasdaq.
NYMT posts Q2 net loss of $3.5M; EAD of $0.22 per share, book value $9.11
Net loss attributable to common stockholders of $3.5M ($0.04 per share); earnings available for distribution of $20.0M ($0.22 per share).
NYMT acquires remaining 50% stake in Constructive Loans, boosting business-purpose lending platform
All-cash acquisition of remaining 50% ownership in Constructive Loans, a business-purpose loan originator.
NYMT completes $90M issuance of 9.875% Senior Notes due 2030
Issued $90M aggregate principal of 9.875% Senior Notes due 2030, including $5M from over-allotment exercise.
NYMT launches $50M preferred stock ATM; amends 5.75% notes covenant to 8:1 debt-to-equity
Entered Equity Distribution Agreement with JonesTrading to sell up to $50M aggregate of Series D, E, F, G preferred stock at-the-market.
NYMT Q1 2025 net income $30.3M, EPS $0.33; book value $9.37
Net income attributable to common stockholders $30.3M ($0.33 basic EPS).
NYMT reports Q4 2024 net loss of $0.46/share; full year loss $1.14/share
Q4 2024 net loss attributable to common stockholders $41.8 million ($0.46 per basic share).
NYMT reports Q3 2024 net income $32.4M ($0.36/share); book value $9.83
Net income attributable to common stockholders $32.4M ($0.36 basic EPS).
NYMT Q2 2024 net loss of $26M; book value $9.69 per share
Net loss attributable to common stockholders of $26.0M ($0.29 per share) for Q2 2024.
NYMT issues $60M of 9.125% Senior Notes due 2029
Issued $60M principal of 9.125% Senior Notes due July 1, 2029, at par.
NYMT reports Q1 2024 net loss $68.3M ($0.75 per share), book value $10.21
Net loss attributable to common stockholders was $68.3M vs. $0.20 dividend per share.
NYMT reports Q4 2023 net income of $31.5M; full year net loss of $90M
Q4 net income $31.5M ($0.35 diluted EPS) vs full year net loss $90M ($0.99 loss per share).
Q3 net loss of $94.8M ($1.04/share); book value $11.26 per share
Net loss attributable to common stockholders of $94.8M, or $1.04 per basic share, for Q3 2023.
NYMT Q2 2023 net loss $37.2M ($0.41/share); dividends $0.30
Net loss attributable to common stockholders $37.2 million; $0.41 loss per share.
NYMT Q1 net income $10.5M, EPS $0.12; dividend $0.40 exceeds EPS
Net income attributable to common stockholders $10.5M, basic EPS $0.12 (post 1:4 reverse split effective 3/9/23).
NYMT reports Q4 2022 net loss of $48M, full-year loss $341M; announces reverse stock split
Q4 net loss attributable to common stockholders $48.1M ($0.13/sh); full year $340.6M ($0.90/sh).
NYMT reports Q3 2022 net loss of $125.8M ($0.33/share); book value falls to $3.65
Net loss attributable to common stockholders of $125.8M ($0.33 basic loss per share); comprehensive loss $126.9M.
NYMT prelim Q3 book value $3.62-$3.66, down from $4.06 at Q2 end; repurchased 5.5M shares at $2.62
Book value per common share estimated at $3.62-$3.66 versus $4.06 at June 30, 2022, a decline of about 10%.
Nathan R. Reese, the Company’s Chief Operating Officer (“COO”) and Secretary, notified the Company that he was resigning as COO and Secretary of the Company to pursue other opportunities, with his resignation from those roles effective immediately.
Mr. Mumma, who most recently served as Executive Chairman of the Company, will continue to serve as Chair of the Board of Directors (the “Board”) of the Company.
appointed Nicholas Mah, who presently serves as a Managing Director of the Company, as President of the Company, effective on January 1, 2023
Jason T. Serrano, the Company’s current Chief Executive Officer and President, will relinquish his role as President but will continue in his role of Chief Executive Officer of the Company.
The Employment Agreements adjust the positions, compensation, and other terms of employment for Messrs. Mumma and Serrano to reflect the appointments of Mr. Mumma as Executive Chairman of the Company and Mr. Serrano as Chief Executive Officer and President of the Company, each effective as of January 1, 2022.
The Employment Agreements adjust the positions, compensation, and other terms of employment for Messrs. Mumma and Serrano to reflect the appointments of Mr. Mumma as Executive Chairman of the Company and Mr. Serrano as Chief Executive Officer and President of the Company, each effective as of January 1, 2022.
and Steven R. Mumma, who presently serves as the Chairman of the Board and Chief Executive Officer of the Company, as Executive Chairman of the Company, effective on January 1, 2022
The Board of Directors of the Company (the “Board”) has appointed Jason T. Serrano as President and Chief Executive Officer of the Company, effective on January 1, 2022
unanimously approved the appointment of Audrey E. Greenberg as a director of the Company, effective as of July 9, 2021
Max materiality 0.80 · Median 0.55 · Most common event earnings